Drug repurposing and optimisation to improve tuberculosis treatment
dc.contributor.advisor | Svensson, Elin M. | en_ZA |
dc.contributor.advisor | Reuter, Helmuth | en_ZA |
dc.contributor.advisor | Diacon, Andreas H. | en_ZA |
dc.contributor.author | Abulfathi, Ahmed Aliyu | en_ZA |
dc.contributor.other | Stellenbosch University. Faculty of Medicine and Health Sciences. Dept. of Medicine: Clinical Pharmacology. | en_ZA |
dc.date.accessioned | 2021-05-18T08:00:28Z | |
dc.date.available | 2021-05-18T08:00:28Z | |
dc.date.issued | 2021-03 | |
dc.description | Thesis (PhD)--Stellenbosch University, 2021. | en_ZA |
dc.description.abstract | ENGLISH ABSTRACT: Tuberculosis, a leading infectious cause of mortality, morbidity, and reduced quality of life with loss of income, remains a huge public health burden particularly in resource-limited settings. The golden thread throughout this dissertation, was improving tuberculosis treatment through repurposing and optimisation of existing medicines. For that purpose, we sought to improve our understanding of the pharmacokinetics and pharmacodynamics of selected anti-tuberculosis drugs. | en_ZA |
dc.description.abstract | AFRIKAANSE OPSOMMING: Tuberkulose, ‘n hoofoorsaak van infeksiesiekte mortaliteit, morbiditeit en verlaagte lewenskwaliteit met verlies aan inkomste, bly ‘n enorme publieke gesondheidslas, veral in omgewings met beperkte hulpbronne. Ons het met hierdie tesis deurlopend beoog om tuberkulose behandeling deur die heroormerking en optimisering van bestaande medisynes te verbeter. Ten einde hierdie doel te bereik, het ons dit ten doel gestel om ons begrip van die farmakokinetika en farmakodinamika van gekose teen-tuberkulose middels te bevorder. | en_ZA |
dc.description.version | Doctoral | en_ZA |
dc.format.extent | 228 pages | en_ZA |
dc.identifier.uri | http://hdl.handle.net/10019.1/110465 | |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | Stellenbosch : Stellenbosch University | en_ZA |
dc.rights.holder | Stellenbosch University | en_ZA |
dc.subject | UCTD | en_ZA |
dc.subject | Rifampicin | en_ZA |
dc.subject | Tuberculosis -- Treatment | en_ZA |
dc.subject | Pharmacokinetics | en_ZA |
dc.subject | Tuberculosis vaccines | en_ZA |
dc.subject | Pulmonary tuberculosis | en_ZA |
dc.title | Drug repurposing and optimisation to improve tuberculosis treatment | en_ZA |
dc.type | Thesis | en_ZA |